241 related articles for article (PubMed ID: 21881850)
21. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
Biochem J; 2006 Jan; 393(Pt 1):255-65. PubMed ID: 16173915
[TBL] [Abstract][Full Text] [Related]
22. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G
Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688
[TBL] [Abstract][Full Text] [Related]
23. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
Zeya B; Arjuman A; Chandra NC
Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
[TBL] [Abstract][Full Text] [Related]
24. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
25. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells.
Aramaki Y; Mitsuoka H; Toyohara M; Jinnai T; Kanatani K; Nakajima K; Mukai E; Yamada Y; Kita T; Inagaki N; Kume N
Atherosclerosis; 2008 Jun; 198(2):272-9. PubMed ID: 18282574
[TBL] [Abstract][Full Text] [Related]
26. Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophy induced by oxidized low-density lipoprotein.
Zhao Y; Li Y; Ning X; Chen K; Zhang S
Biochem Biophys Res Commun; 2017 Aug; 490(1):55-61. PubMed ID: 28595908
[TBL] [Abstract][Full Text] [Related]
27. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.
Mitra S; Deshmukh A; Sachdeva R; Lu J; Mehta JL
Am J Med Sci; 2011 Aug; 342(2):135-42. PubMed ID: 21747278
[TBL] [Abstract][Full Text] [Related]
28. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains.
Wang X; Ding Z; Lin J; Guo Z; Mehta JL
Biochem Biophys Res Commun; 2015 Nov; 467(1):135-9. PubMed ID: 26393906
[TBL] [Abstract][Full Text] [Related]
29. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.
Wang Z; Chen J; Zeng Z; Zhang Q; Du G; Guo X; Wei Y
Mol Med; 2022 Mar; 28(1):26. PubMed ID: 35236285
[TBL] [Abstract][Full Text] [Related]
30. Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits.
Li S; Guo Y; Zhu P; Yang T
Vascul Pharmacol; 2013; 59(5-6):131-7. PubMed ID: 23022624
[TBL] [Abstract][Full Text] [Related]
31. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis.
Hashimoto K; Mori S; Oda Y; Nakano A; Sawamura T; Akagi M
Scand J Rheumatol; 2016 Oct; 45(5):412-22. PubMed ID: 26901593
[TBL] [Abstract][Full Text] [Related]
32. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
33. Lectin-like oxidized LDL receptor-1 expresses in mouse bone marrow-derived mesenchymal stem cells and stimulates their proliferation.
Zhang F; Wang C; Jing S; Ren T; Li Y; Cao Y; Lin J
Exp Cell Res; 2013 Apr; 319(7):1054-9. PubMed ID: 23399833
[TBL] [Abstract][Full Text] [Related]
34. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
Mango R; Predazzi IM; Romeo F; Novelli G
Cardiovasc Drugs Ther; 2011 Oct; 25(5):489-94. PubMed ID: 21904818
[TBL] [Abstract][Full Text] [Related]
35. LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.
Yan M; Mehta JL; Zhang W; Hu C
Cardiovasc Drugs Ther; 2011 Oct; 25(5):451-9. PubMed ID: 21993919
[TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
37. Roles of LOX-1 in microvascular dysfunction.
Lubrano V; Balzan S
Microvasc Res; 2016 May; 105():132-40. PubMed ID: 26907636
[TBL] [Abstract][Full Text] [Related]
38. Oxidized low-density lipoprotein attenuated desmoglein 1 and desmocollin 2 expression via LOX-1/Ca(2+)/PKC-β signal in human umbilical vein endothelial cells.
Li YB; Zhang QH; Chen Z; He ZJ; Yi GH
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):380-6. PubMed ID: 26498522
[TBL] [Abstract][Full Text] [Related]
39. Do atherosclerosis and obesity-associated susceptibility to cancer share causative link to oxLDL and LOX-1?
Khaidakov M; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):477-87. PubMed ID: 21881851
[No Abstract] [Full Text] [Related]
40. Effects of flow on LOX-1 and oxidized low-density lipoprotein interactions in brain endothelial cell cultures.
Mao X; Xie L; Greenberg DA
Free Radic Biol Med; 2015 Dec; 89():638-41. PubMed ID: 26462413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
